Cargando…
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
Numerous biologic approaches are being investigated as anti-cancer therapies in an attempt to induce tumor regression while circumventing the toxic side effects associated with standard chemo- or radiotherapies. Among these, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown p...
Autores principales: | Norian, Lyse A., James, Britnie R., Griffith, Thomas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756379/ https://www.ncbi.nlm.nih.gov/pubmed/24212631 http://dx.doi.org/10.3390/cancers3010603 |
Ejemplares similares
-
Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012) -
Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy
por: Norian, Lyse A., et al.
Publicado: (2012) -
Advances in Non-Viral DNA Vectors for Gene Therapy
por: Hardee, Cinnamon L., et al.
Publicado: (2017) -
Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023) -
Checkpoint inhibitors in ovarian cancer: A review of preclinical data
por: Doo, David W., et al.
Publicado: (2019)